Current Scenario of Patent Act: Compulsory Licensing
暂无分享,去创建一个
[1] Randall Kuhn,et al. Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis , 2012, PLoS medicine.
[2] Swarup Kumar,et al. Compulsory Licensing Provision Under TRIPS: A Study of Roche vs. NATCO Case in India Vis-a-vis the Applicability of the Principle of Audi Alteram Partem , 2010 .
[3] J. Reichman. Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options , 2009, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
[4] Harshita Mathur,et al. Compulsory Licensing under Section 92A: Issues and Concerns , 2008 .
[5] N. Lalitha. Doha Declaration and Public Health Issues , 2008 .
[6] D. Matthews. Lessons from Negotiating an Amendment to the TRIPs Agreement: Compulsory Licensing and Access to Medicines , 2007 .
[7] Erik Alsegard. Global Pharmaceutical Patents after the Doha Declaration - What Lies in the Future , 2004 .
[8] Deli Yang. Compulsory Licensing: For Better or For Worse, the Done Deal Lies in the Balance , 2012 .
[9] Aileen M McGill. Compulsory Licensing of Patented Pharmaceuticals: Why a WTO Administrative Body Should Determine What Constitues a Public Health Crisis under the Doha Declaration , 2009 .
[10] J. Feldman. Compulsory Licenses: The Dangers Behind the Current Practice , 2009 .